Joe
07-23-2007, 05:30 PM
Before the osteoporosis drug Evista is approved for breast cancer in the U.S. the Food and Drug Administration (FDA) will take the advice of an advisory panel.
More... (http://www.news-medical.net/?id=27948)
More... (http://www.news-medical.net/?id=27948)